Autoantigens of the nuclear pore complex

被引:28
作者
Enarson, P
Rattner, JB
Ou, Y
Miyachi, K
Horigome, T
Fritzler, MJ
机构
[1] Univ Calgary, Dept Med, Fac Med, Calgary, AB T2N 4N1, Canada
[2] Univ Calgary, Dept Anat & Cell Biol, Fac Med, Calgary, AB T2N 4N1, Canada
[3] Hlth Sci Res Inst, Kanagawa, Japan
[4] Niigata Univ, Fac Sci, Dept Chem, Niigata, Japan
来源
JOURNAL OF MOLECULAR MEDICINE-JMM | 2004年 / 82卷 / 07期
关键词
nuclear envelope; nuclear pore complex; autoantibodies; autoimmune diseases; antigens;
D O I
10.1007/s00109-004-0554-z
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The nuclear envelope (NE) is one of many intracellular targets of the autoimmune response in patients with autoimmune liver disease, systemic lupus erythematosus, and related conditions. In eukaryotic organisms the NE consists of five interconnected regions: an outer nuclear membrane (ONM) that is continuous with the endoplasmic reticulum, an intermembrane or perinuclear space, an inner nuclear membrane (INM) with a unique set of integral membrane proteins, the underlying nuclear lamina, and the pore domains that are regions where the ONM and INM come together. The pore domains are sites of regulated continuity between the cytoplasm and nucleus that are occupied by supramolecular structures, termed nuclear pore complexes (NPCs). Human autoantibodies identified to date bind to specific components in three of the five NE compartments. Autoantigen targets include the lamins A, B, and C of the nuclear lamina, gp210, p62 complex proteins, Nup153, and Tpr within the NPC, and LBR, MAN1, LAP1, and LAP2 that are integral proteins of the INM. Autoantibodies to these NE targets have been shown to be correlated with various autoimmune diseases such as primary biliary cirrhosis, other autoimmune liver diseases and systemic rheumatic diseases. Now that the proteome of the NE is more clearly defined, other autoantibodies to components in this cell compartment are likely to be defined.
引用
收藏
页码:423 / 433
页数:11
相关论文
共 114 条
  • [1] A review of the evidence for overlap among unexplained clinical conditions
    Aaron, LA
    Buchwald, D
    [J]. ANNALS OF INTERNAL MEDICINE, 2001, 134 (09) : 868 - 881
  • [2] ARCHITECTURE OF THE XENOPUS NUCLEAR-PORE COMPLEX REVEALED BY 3-DIMENSIONAL CRYOELECTRON MICROSCOPY
    AKEY, CW
    RADERMACHER, M
    [J]. JOURNAL OF CELL BIOLOGY, 1993, 122 (01) : 1 - 19
  • [3] BALCZON R, 1993, P SOC EXP BIOL MED, V204, P138
  • [4] Bandin O, 1996, HEPATOLOGY, V23, P1020
  • [5] Nup84, a novel nucleoporin that is associated with CAN/Nup214 on the cytoplasmic face of the nuclear pore complex.
    Bastos, R
    dePouplana, LR
    Enarson, M
    Bodoor, K
    Burke, B
    [J]. JOURNAL OF CELL BIOLOGY, 1997, 137 (05) : 989 - 1000
  • [6] Nucleocytoplasmic transport: Navigating the channel
    Bednenko, J
    Cingolani, G
    Gerace, L
    [J]. TRAFFIC, 2003, 4 (03) : 127 - 135
  • [7] An evolutionarily conserved NPC subcomplex, which redistributes in part to kinetochores in mammalian cells
    Belgareh, N
    Rabut, G
    Baï, SW
    van Overbeek, M
    Beaudouin, J
    Daigle, N
    Zatsepina, OV
    Pasteau, F
    Labas, V
    Fromont-Racine, M
    Ellenberg, J
    Doye, V
    [J]. JOURNAL OF CELL BIOLOGY, 2001, 154 (06) : 1147 - 1160
  • [8] Function and assembly of nuclear pore complex proteins
    Bodoor, K
    Shaikh, S
    Enarson, P
    Chowdhury, S
    Salina, D
    Raharjo, WH
    Burke, B
    [J]. BIOCHEMISTRY AND CELL BIOLOGY-BIOCHIMIE ET BIOLOGIE CELLULAIRE, 1999, 77 (04): : 321 - 329
  • [9] Bodoor K, 1999, J CELL SCI, V112, P2253
  • [10] Chan EKL, 1998, UPDAT CLIN IMMUNOL, V9, P85